M T Lotze

5.4k total citations · 2 hit papers
54 papers, 4.4k citations indexed

About

M T Lotze is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, M T Lotze has authored 54 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Immunology, 31 papers in Oncology and 13 papers in Molecular Biology. Recurrent topics in M T Lotze's work include Immunotherapy and Immune Responses (22 papers), Cancer Immunotherapy and Biomarkers (14 papers) and Immune Cell Function and Interaction (11 papers). M T Lotze is often cited by papers focused on Immunotherapy and Immune Responses (22 papers), Cancer Immunotherapy and Biomarkers (14 papers) and Immune Cell Function and Interaction (11 papers). M T Lotze collaborates with scholars based in United States, Germany and Malaysia. M T Lotze's co-authors include Walter J. Storkus, Christina M. Celluzzi, Louis D. Falo, José Mayordomo, S A Rosenberg, Laurence Zitvogel, S T Ildstad, Cornelis J.M. Melief, Tatiana Zorina and Albert B. DeLeo and has published in prestigious journals such as Journal of Clinical Investigation, Nature Medicine and The Journal of Experimental Medicine.

In The Last Decade

M T Lotze

54 papers receiving 4.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity

1995 928 citations José Mayordomo, Tatiana Zorina et al. Nature Medicine profile →
Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity.

1996 626 citations Christina M. Celluzzi, José Mayordomo et al. The Journal of Experimental Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M T Lotze United States	31	3.5k	1.7k	1.4k	557	427	54	4.4k
Susan Schwarz United States	18	3.0k 0.9×	1.6k 1.0×	1.2k 0.9×	355 0.6×	324 0.8×	24	3.7k
A Lazenby United States	14	2.6k 0.7×	1.6k 1.0×	1.3k 1.0×	1.0k 1.8×	202 0.5×	21	3.9k
Amy Hobeika United States	34	2.5k 0.7×	1.7k 1.0×	2.0k 1.5×	318 0.6×	296 0.7×	90	4.2k
Paul Aebersold United States	17	2.7k 0.8×	2.8k 1.7×	1.6k 1.1×	1.3k 2.4×	316 0.7×	29	4.9k
R. L. H. Bolhuis Netherlands	37	3.2k 0.9×	2.0k 1.2×	795 0.6×	484 0.9×	997 2.3×	105	4.6k
Laura Bover United States	26	2.3k 0.7×	926 0.6×	936 0.7×	329 0.6×	156 0.4×	58	3.7k
Maha Ayyoub France	33	3.2k 0.9×	1.4k 0.9×	1.3k 1.0×	235 0.4×	177 0.4×	84	4.2k
Laura S. Grosmaire United States	24	3.9k 1.1×	924 0.6×	807 0.6×	405 0.7×	689 1.6×	39	4.9k
Mojgan Ahmadzadeh United States	23	4.7k 1.3×	3.4k 2.1×	984 0.7×	478 0.9×	271 0.6×	30	5.9k
John R. Yannelli United States	34	5.5k 1.6×	3.6k 2.2×	2.2k 1.6×	793 1.4×	597 1.4×	74	7.3k

Countries citing papers authored by M T Lotze

Since Specialization

Citations

This map shows the geographic impact of M T Lotze's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M T Lotze with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M T Lotze more than expected).

Fields of papers citing papers by M T Lotze

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M T Lotze. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M T Lotze. The network helps show where M T Lotze may publish in the future.

Co-authorship network of co-authors of M T Lotze

This figure shows the co-authorship network connecting the top 25 collaborators of M T Lotze. A scholar is included among the top collaborators of M T Lotze based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M T Lotze. M T Lotze is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Karyampudi, Lavakumar, et al.. (2017). Phenotypic and functional characterization of tumor infiltrating lymphocytes (TIL) grown from non-hodgkin lymphoma tumors: Implications for the development of novel therapies for lymphoma. Annals of Oncology. 28. v363–v363. 1 indexed citations

Lotze, M T, et al.. (1997). CREATING IMMUNE PRIVILEGE. Journal of Immunotherapy. 20(5). 402–402. 1 indexed citations

Maeurer, Markus, David E. Martin, W. Walter, et al.. (1996). Human intestinal Vdelta1+ lymphocytes recognize tumor cells of epithelial origin.. The Journal of Experimental Medicine. 183(4). 1681–1696. 124 indexed citations

Celluzzi, Christina M., José Mayordomo, Walter J. Storkus, M T Lotze, & Louis D. Falo. (1996). Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity.. The Journal of Experimental Medicine. 183(1). 283–287. 626 indexed citations breakdown →

Maeurer, Markus, Susanne M. Gollin, D Martin, et al.. (1996). Tumor escape from immune recognition: lethal recurrent melanoma in a patient associated with downregulation of the peptide transporter protein TAP-1 and loss of expression of the immunodominant MART-1/Melan-A antigen.. Journal of Clinical Investigation. 98(7). 1633–1641. 228 indexed citations

Leder, Gerhard, et al.. (1996). Inhibition of Nitric Oxide Synthesis Does Not Improve Interleukin-2-Mediated Antitumor Effects in vivo. European Surgical Research. 28(3). 167–178. 1 indexed citations

Galon, Jérôme, J F Gauchat, Roberto Spagnoli, et al.. (1996). Soluble Fcγ receptor type III (FcγRIII, CD16) triggers cell activation through interaction with complement receptors. The Journal of Immunology. 157(3). 1184–1192. 91 indexed citations

Nishihara, Kazuyo, Rolf F. Barth, Neil Wilkie, et al.. (1995). Increased in vitro and in vivo tumoricidal activity of a macrophage cell line genetically engineered to express IFN-gamma, IL-4, IL-6, or TNF-alpha.. PubMed. 2(2). 113–24. 15 indexed citations

Mayordomo, José, Tatiana Zorina, Walter J. Storkus, et al.. (1995). Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity. Nature Medicine. 1(12). 1297–1302. 928 indexed citations breakdown →

10.

Irshaid, Yacoub M., Adedayo Adedoyin, M T Lotze, & Robert A. Branch. (1994). Monoacetyldapsone inhibition of dapsone N-hydroxylation by human and rat liver microsomes.. Drug Metabolism and Disposition. 22(1). 161–164. 9 indexed citations

11.

Stötter, H, et al.. (1991). IL-7 induces human lymphokine-activated killer cell activity and is regulated by IL-4. The Journal of Immunology. 146(1). 150–155. 65 indexed citations

12.

Sakahara, Harumi, Jorge A. Carrasquillo, Patrick J. Maloney, et al.. (1989). In vitro complex formation and biodistribution of mouse antitumor monoclonal antibody in cancer patients.. PubMed. 30(8). 1311–7. 34 indexed citations

13.

Lotze, M T & Steven A. Rosenberg. (1988). The Immunologic Treatment Of Cancer. CA A Cancer Journal for Clinicians. 38(2). 68–94. 13 indexed citations

14.

Kawakami, Yutaka, Steven A. Rosenberg, & M T Lotze. (1988). Interleukin 4 promotes the growth of tumor-infiltrating lymphocytes cytotoxic for human autologous melanoma.. The Journal of Experimental Medicine. 168(6). 2183–2191. 139 indexed citations

15.

Wiebke, Eric A., M T Lotze, & Steven A. Rosenberg. (1987). Tumor cell susceptibility to lysis: Marked increase in lysis by tumor-infiltrating lymphocytes following target stimulation with interferon-γ and tumor necrosis factor-α - Implications for immunotherapy. 38. 436–438. 1 indexed citations

16.

Lotze, M T, Jorge A. Carrasquillo, John N. Weinstein, et al.. (1986). Monoclonal Antibody Imaging of Human Melanoma. Annals of Surgery. 204(3). 223–235. 34 indexed citations

17.

Donohue, J H, Maury Rosenstein, Alfred E. Chang, et al.. (1984). The systemic administration of purified interleukin 2 enhances the ability of sensitized murine lymphocytes to cure a disseminated syngeneic lymphoma.. The Journal of Immunology. 132(4). 2123–2128. 114 indexed citations

18.

Lotze, M T, Bruce R. Line, Douglas J. Mathisen, & S A Rosenberg. (1980). The in vivo distribution of autologous human and murine lymphoid cells grown in T cell growth factor (TCGF): implications for the adoptive immunotherapy of tumors.. The Journal of Immunology. 125(4). 1487–1493. 175 indexed citations

19.

Lotze, M T, John L. Strausser, Bruce R. Line, & Steven A. Rosenberg. (1980). Tumor lysis by human T lymphocytes in long-term culture and their distribution in vivo; implications for immunotherapy. 31. 404–406. 1 indexed citations

20.

Lotze, M T, John L. Strausser, & S A Rosenberg. (1980). In vitro growth of cytotoxic human lymphocytes. II. Use of T cell growth factor (TCGF) to clone human T cells.. The Journal of Immunology. 124(6). 2972–2978. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact